Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/1996
11/19/1996US5576205 Kainate-binding human CNS receptors of the EAA1 family
11/19/1996US5576193 Protein having human plasmin inhibiting activity
11/19/1996US5576192 Prostaglandin E receptors, their DNA and production
11/19/1996US5576190 Bacteriophage Lambda pL promoters
11/19/1996US5576189 Antibody to type-I collagen amino-terminal telopeptide
11/19/1996US5576188 Immunological detection of metolachlor
11/19/1996US5576183 Monoclonal antibody recognizing FK506-binding protein, method for assaying FK506-binding protein level, and kit therefor
11/19/1996US5576182 Anti-mucus glycoprotein monoclonal antibody
11/19/1996US5576026 Lumbricus product and method of making same
11/19/1996US5576000 Envelope protein of hiv with sequences
11/14/1996WO1996035951A1 Novel peptides and compositions which modulate apoptosis
11/14/1996WO1996035788A2 Kunitz type protease inhibitors
11/14/1996WO1996035787A1 Nucleic acids for treating obesity
11/14/1996WO1996035774A2 Angiostatin fragments and aggregate angiostatin and methods of use
11/14/1996WO1996035719A1 Transeptithelial transport of molecular species
11/14/1996WO1996035718A1 Process for producing erythropoietin containing no animal proteins
11/14/1996WO1996035716A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996WO1996035449A1 Monoclonal antibodies for the treatment of ulcerative colitis
11/14/1996WO1996035439A1 Low molecular yeast active substance extract and process for preparing the same
11/14/1996WO1996035339A1 FEED COMPOSITION CONTAINING POLY-η-GLUTAMIC ACID
11/14/1996CA2220939A1 A feed composition containing poly-gamma-glutamic acid
11/14/1996CA2220917A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996CA2220497A1 Kunitz type protease inhibitors
11/14/1996CA2218529A1 Nucleic acids for treating obesity
11/13/1996EP0742229A2 Induction of protection against viral infection
11/13/1996EP0742014A1 MHC-peptide labelled conjugates
11/13/1996EP0741792A1 Herpesvirus pre-(viral dna replication) enveloped
11/13/1996EP0741789A1 Process for the production of a heterologous protein from a methylotrophic yeast
11/13/1996EP0741788A1 Inducing tolerance with tolerogenic fusion proteins
11/13/1996EP0741787A1 Mammalian expression systems for hepatitis c virus envelope genes
11/13/1996EP0741785A1 Methods and compositions for stimulating bone cells
11/13/1996EP0741784A1 Ligand (act-4-l) to a receptor on the surface of activated cd4?+ t-cells
11/13/1996EP0741783A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins
11/13/1996EP0741782A1 Glutamate receptor (or eaa receptor) polynucleotides and their uses
11/13/1996EP0741748A1 Monoclonal antibodies specific to vegf receptors and uses thereof
11/13/1996EP0741578A1 Human growth hormone
11/13/1996EP0741576A1 Co-administration of interleukin-3 mutants with colony stimulating factors
11/13/1996EP0741515A1 Transgenic production of antibodies in milk
11/13/1996EP0589877B1 METHODS FOR PRODUCING FUNCTIONAL, SINGLE-CHAIN Fv ANTIBODY FRAGMENTS ON THE SURFACE OF BACTERIOPHAGE PARTICLES
11/13/1996EP0480014B1 SYNTHETIC POLY-Ig RECEPTOR, RECEPTOR-ANTIBODY COMPLEXES, PRODUCTION AND USE THEREOF
11/13/1996EP0474691B1 Monoclonal antibodies for inducing tolerance
11/13/1996EP0434744B1 Serum immunoregulatory polypeptide and uses therefor
11/13/1996EP0373168B1 Polypeptide useful in diagnosis of coccidia infection and recombinant-dna methods for manufacturing same
11/13/1996CN1135771A DNA sequence coding for a BMP receptor
11/13/1996CN1135759A Membrane protein polypeptide having functions of supporting pre-B cell growth and gene thereof
11/12/1996US5574144 Kainate-binding, human CNS receptors of the EAA4 family
11/12/1996US5574137 Recombinant gamma interferons having enhanced stability and methods therefor
11/12/1996US5574132 Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
11/12/1996US5573957 Monoclonal antibody to human cardiac myoglobin
11/12/1996US5573943 Cloning and expression of a rhoptry associated protein of P. falciparum
11/12/1996US5573938 Genetic engineering
11/12/1996US5573936 Fungicide
11/12/1996US5573924 Novel receptor cytokine, protein
11/12/1996US5573923 Method for removing N-terminal dipeptides from precursor polypeptides with immobilized dipeptidylaminopeptidase from dictyostelium discoideum
11/12/1996US5573920 Antibodies, and methods for their use
11/12/1996US5573766 Application to plants, active against lepidoptera and coleoptera
11/12/1996US5573763 Family of CSF-l proteins
11/12/1996CA1338707C Protein h being capable of binding to igg, gene coding for the said protein h and a process for producing the said protein h
11/12/1996CA1338706C Monoclonal anti-human breast cancer antibodies suitable for imaging breast cancer
11/12/1996CA1338705C Vaccines obtained from antigenic gene products of recombinant genes
11/07/1996WO1996034974A1 Low oxygen affinity mutant hemoglobin
11/07/1996WO1996034970A1 Improved methods for transfecting t cells
11/07/1996WO1996034964A2 Stable variant hk2 polypeptide
11/07/1996WO1996034960A1 High molecular weight major outer membrane protein of moraxella
11/07/1996WO1996034951A1 Gdu, a novel signalling protein
11/07/1996WO1996034949A1 Plant promoter activated by fungal infection
11/07/1996WO1996034948A1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp
11/07/1996WO1996034940A1 Dna encoding glutamate gated chloride channels
11/07/1996WO1996034893A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits
11/07/1996WO1996034892A1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034888A1 Modulation of cholesteryl ester transfer protein (cetp) activity
11/07/1996WO1996034885A2 Biologically active peptide fragments of ob protein
11/07/1996WO1996034880A1 Cd6 ligand
11/07/1996WO1996034622A1 Modified myelin protein molecules
11/07/1996WO1996030520A3 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
11/07/1996WO1996029409A3 Rage tumor rejection antigens
11/07/1996CA2220333A1 Plant promoter activated by fungal infection
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2220109A1 Engineering protein posttranslational modification in transgenic organisms
11/07/1996CA2220098A1 Cd6 ligand
11/07/1996CA2220016A1 Gdu, a novel signalling protein
11/07/1996CA2219889A1 High molecular weight major outer membrane protein of moraxella
11/07/1996CA2218858A1 Modified myelin protein molecules
11/06/1996EP0741187A2 Recombinant obese (Ob) proteins
11/06/1996EP0741144A1 Antiannexin-v monoclonal antibody, process for producing the same, and use therof
11/06/1996EP0740707A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms
11/06/1996EP0740705A1 THERMOSTABLE VARIANTS OF NEUTRAL PROTEASES OF $i(BACILLUS STEAROTHERMOPHILUS) AND $i(BACILLUS THERMOPROTEOLYTICUS)
11/06/1996EP0740704A1 Immunization by inoculation of dna transcription unit
11/06/1996EP0740703A1 Diagnosis and treatment of infections due to streptococci and enterococci
11/06/1996EP0740701A1 Mammalian monocyte chemoattractant protein receptors
11/06/1996EP0740700A1 Natural resistance associated macrophage protein and uses thereof
11/06/1996EP0740699A1 Cell lines, maturation factors and use of said cell lines and factors
11/06/1996EP0740553A1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells
11/06/1996EP0729361A4 Method of treating neurological disorders
11/06/1996EP0652901A4 Carboxy terminal il-6 muteins.
11/06/1996EP0590034B1 Method for determining the presence of diabetes associated antibodies or islet cell directed antibodies
11/06/1996CN1135237A Products that elicit neutralizing antibodies against genetically divergent HIV-1 strains
1 ... 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 ... 1125